Siying Wang
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Siying Wang has a total of 15 co-authors. Here are the top co-authors by number of shared publications:
- Dongmei Zhao
Key Laboratory of Forest Plant Ecology, Northeast Forestry University, Ministry of Education, Harbin 150040, China
1 shared publication - Feng Han
College of Grassland Science, Inner Mongolia Agricultural University, Hohhot 010011, China
1 shared publication Haishun Xu
National Key Laboratory for Development and Utilization of Forest Food Resources, Zhejiang Provincial Key Laboratory of Characteristic Traditional Chinese Medicine Resources Protection and Innovative Utilization, National Innovation Alliance of Lingzhi and Sanyeqing Industry, College of Food and Health Zhejiang A&F University Hangzhou PR China
1 shared publicationJuan Xu
National Key Laboratory for Development and Utilization of Forest Food Resources, Zhejiang Provincial Key Laboratory of Characteristic Traditional Chinese Medicine Resources Protection and Innovative Utilization, National Innovation Alliance of Lingzhi and Sanyeqing Industry, College of Food and Health Zhejiang A&F University Hangzhou PR China
1 shared publication- Lanlan Xie
Key Laboratory of Forest Plant Ecology, Ministry of Education, Northeast Forestry University, Harbin, 150040, People’s Republic of China
1 shared publication Qilei Yang
Key Laboratory of Forest Plant Ecology, Ministry of Education, Northeast Forestry University, Harbin, 150040, People’s Republic of China
1 shared publication
Latest Publications
- 19 January 2026
- Published by Wiley in Physiologia Plantarum
- Vol. 178 (1) , e70746
Integrated Hormonal and Transcriptomic Analysis Reveals Mechanisms of Tuberous Root Formation in Tetrastigma hemsleyanum
Tetrastigma hemsleyanum Diels et Gilg ( T. hemsleyanum ) is a plant of considerable medicinal and economic value. However, the molecular mechanisms underlying its tuberous root formation remain poorly understood. To investigate the molecular basis of tuberous root formation, we analyzed hormonal metabolic levels, transcriptomic profiles, and root anatomical changes during this process. Using ultra‐performance liquid chromatography‐electrospray ionization tandem mass spectrometry, we quantitatively assessed the levels of eight plant hormones and their derivatives in the early stages of tuberous root formation and in adventitious roots. The results revealed significant fluctuations in hormone levels, with a marked upregulation of cytokinins (tZ, DZ, and IP) and the complete absence of gibberellin GA 1 post‐tuberous root formation. Jasmonic acid content decreased, while methyl jasmonate (MeJA) increased substantially. Exogenous application of MeJA further confirmed the role of the jasmonic acid pathway in tuberous root formation, underscoring the pivotal role of these hormones in root differentiation and expansion. Additionally, transcriptomic analysis identified significant alterations in biological processes associated with the cytoskeleton and cell wall during tuberous root formation. Anatomical observations indicated reduced lignification and a notable increase in vascular cambium and xylem parenchyma cells. In conclusion, this study provides valuable insights into the molecular mechanisms of tuberous root formation in T. hemsleyanum , emphasizing the critical role of plant hormones and offering new strategies for enhancing tuber growth and yield through hormonal regulation.
- 19 January 2026
- Published by Wiley in Physiologia Plantarum
- Vol. 178 (1) , e70746
Integrated Hormonal and Transcriptomic Analysis Reveals Mechanisms of Tuberous Root Formation in Tetrastigma hemsleyanum
Tetrastigma hemsleyanum Diels et Gilg ( T. hemsleyanum ) is a plant of considerable medicinal and economic value. However, the molecular mechanisms underlying its tuberous root formation remain poorly understood. To investigate the molecular basis of tuberous root formation, we analyzed hormonal metabolic levels, transcriptomic profiles, and root anatomical changes during this process. Using ultra‐performance liquid chromatography‐electrospray ionization tandem mass spectrometry, we quantitatively assessed the levels of eight plant hormones and their derivatives in the early stages of tuberous root formation and in adventitious roots. The results revealed significant fluctuations in hormone levels, with a marked upregulation of cytokinins (tZ, DZ, and IP) and the complete absence of gibberellin GA 1 post‐tuberous root formation. Jasmonic acid content decreased, while methyl jasmonate (MeJA) increased substantially. Exogenous application of MeJA further confirmed the role of the jasmonic acid pathway in tuberous root formation, underscoring the pivotal role of these hormones in root differentiation and expansion. Additionally, transcriptomic analysis identified significant alterations in biological processes associated with the cytoskeleton and cell wall during tuberous root formation. Anatomical observations indicated reduced lignification and a notable increase in vascular cambium and xylem parenchyma cells. In conclusion, this study provides valuable insights into the molecular mechanisms of tuberous root formation in T. hemsleyanum , emphasizing the critical role of plant hormones and offering new strategies for enhancing tuber growth and yield through hormonal regulation.
- 1 September 2022
- Published by Taylor & Francis in Nanomedicine
- Vol. 17 (22) , 1627-1648
Preparation and Evaluation of Paclitaxel-Loaded Reactive Oxygen Species and Glutathione Redox-Responsive Poly(Lactic-Co-Glycolic Acid) Nanoparticles for Controlled Release in Tumor Cells
Aim: To formulate and assess the anticancer effect of the poly(lactic-co-glycolic acid) (PLGA) copolymer with the thioether groups (diethyl sulfide [Des]) and disulfide bond (cystamine containing disulfide [Cys]), which encapsulated the anticancer drug paclitaxel (PTX) and triggered PTX release in cancer cell H2O2-rich or glutathione-rich surroundings. Methods: PLGA-b-P (Des@Cys) and PLGA-b-P nanoparticles loaded with PTX were prepared and characterized in vitro. The delivery ability of the PLGA-b-P nanoparticles and PLGA-b-P-PTX nanoparticles was assessed on a CT26 (mouse colon cancer cell line) and mouse lung cancer LLC model. Results: The nanoparticles were successfully prepared. Compared with free PTX, the formulated PLGA-b-P nanoparticles loaded with PTX exhibited greater accumulation at the tumor site in the mouse model. Conclusion: PLGA-b-P nanoparticles promote drug accumulation at tumor sites, providing an effective strategy for an intelligent, responsive drug-delivery system. Tweetable abstractThis study prepared polymer nanocarriers (PLGA-b-p-NPs) with double response to the tumor microenvironment and loaded with traditional antitumor drug paclitaxel, so that drugs can accurately reach tumor cells and be rapidly released in cells. Plain language summaryCancer is one of the diseases with the highest mortality rate in the world. Chemotherapy is the most frequently used method of cancer treatment. However, traditional chemotherapeutic drugs have the disadvantages of lack of specificity, high toxicity to the human body, lack of tumor targeting, inability to exist stably in the body, ease of clearance by the body and drug resistance to tumors, so clinical application is limited. Paclitaxel is widely used in the treatment of various cancers, and its use is limited due to the above disadvantages. The purpose of this study was to construct a nanodelivery system with dual responses to the tumor microenvironment, enabling the efficient accumulation of paclitaxel in solid tumors through the enhanced permeability and retention effect, enhancing the therapeutic effect of cancer. This study also investigated the intravenous safety of this dual-responsive nanodelivery system. It evaluated the toxic effects of drug-loaded nanoparticles on cancer cells and validated the controlled release of nanoparticles at tumor sites by in vivo imaging in mice. The authors concluded that tumor microenvironment dual-responsive nanoparticles are a novel and promising nanodelivery system as an intelligently responsive anticancer agent with great promise in future clinical trials.
- 1 September 2022
- Published by Taylor & Francis in Nanomedicine
- Vol. 17 (22) , 1627-1648
Preparation and Evaluation of Paclitaxel-Loaded Reactive Oxygen Species and Glutathione Redox-Responsive Poly(Lactic-Co-Glycolic Acid) Nanoparticles for Controlled Release in Tumor Cells
Aim: To formulate and assess the anticancer effect of the poly(lactic-co-glycolic acid) (PLGA) copolymer with the thioether groups (diethyl sulfide [Des]) and disulfide bond (cystamine containing disulfide [Cys]), which encapsulated the anticancer drug paclitaxel (PTX) and triggered PTX release in cancer cell H2O2-rich or glutathione-rich surroundings. Methods: PLGA-b-P (Des@Cys) and PLGA-b-P nanoparticles loaded with PTX were prepared and characterized in vitro. The delivery ability of the PLGA-b-P nanoparticles and PLGA-b-P-PTX nanoparticles was assessed on a CT26 (mouse colon cancer cell line) and mouse lung cancer LLC model. Results: The nanoparticles were successfully prepared. Compared with free PTX, the formulated PLGA-b-P nanoparticles loaded with PTX exhibited greater accumulation at the tumor site in the mouse model. Conclusion: PLGA-b-P nanoparticles promote drug accumulation at tumor sites, providing an effective strategy for an intelligent, responsive drug-delivery system. Tweetable abstractThis study prepared polymer nanocarriers (PLGA-b-p-NPs) with double response to the tumor microenvironment and loaded with traditional antitumor drug paclitaxel, so that drugs can accurately reach tumor cells and be rapidly released in cells. Plain language summaryCancer is one of the diseases with the highest mortality rate in the world. Chemotherapy is the most frequently used method of cancer treatment. However, traditional chemotherapeutic drugs have the disadvantages of lack of specificity, high toxicity to the human body, lack of tumor targeting, inability to exist stably in the body, ease of clearance by the body and drug resistance to tumors, so clinical application is limited. Paclitaxel is widely used in the treatment of various cancers, and its use is limited due to the above disadvantages. The purpose of this study was to construct a nanodelivery system with dual responses to the tumor microenvironment, enabling the efficient accumulation of paclitaxel in solid tumors through the enhanced permeability and retention effect, enhancing the therapeutic effect of cancer. This study also investigated the intravenous safety of this dual-responsive nanodelivery system. It evaluated the toxic effects of drug-loaded nanoparticles on cancer cells and validated the controlled release of nanoparticles at tumor sites by in vivo imaging in mice. The authors concluded that tumor microenvironment dual-responsive nanoparticles are a novel and promising nanodelivery system as an intelligently responsive anticancer agent with great promise in future clinical trials.